NRG-HN004 – temporarily closed

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin

For more information about this clinical trial, click here

Schema & Eligibility NRG-HN004

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Clinic Cancer & Hematology, Rolla, MO

Ask your physician about participating in this clinical trial or call us.